Scheie syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Scheie syndrome
File:Mucopolysaccharidosis (Scheie's Syndrome) 1.jpg
Synonyms	MPS I-S, Mucopolysaccharidosis type I
Pronounce
Specialty	Medical genetics
Symptoms	Corneal clouding, joint stiffness, carpal tunnel syndrome, aortic valve disease
Complications	N/A
Onset	Childhood
Duration	Lifelong
Types	N/A
Causes	Genetic mutation in the IDUA gene
Risks	Family history
Diagnosis	Genetic testing, urine test for glycosaminoglycans
Differential diagnosis	Hurler syndrome, Hunter syndrome
Prevention	N/A
Treatment	Enzyme replacement therapy, hematopoietic stem cell transplantation
Medication	Laronidase
Prognosis	N/A
Frequency	Rare
Deaths

A rare genetic disorder

Scheie syndrome is a rare genetic disorder that is classified as a type of mucopolysaccharidosis, specifically Mucopolysaccharidosis type I (MPS I). It is the mildest form of MPS I, with the other forms being Hurler syndrome and Hurler-Scheie syndrome.

Pathophysiology

Scheie syndrome is caused by a deficiency of the enzyme alpha-L-iduronidase, which is responsible for breaking down glycosaminoglycans (GAGs), specifically dermatan sulfate and heparan sulfate. The accumulation of these substances in the body leads to the various symptoms associated with the disorder.

Genetics

Scheie syndrome is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the defective gene, one from each parent, to manifest the disease. The gene responsible for Scheie syndrome is located on chromosome 4p16.3.

Clinical Features

Individuals with Scheie syndrome typically present with symptoms later in childhood or adolescence. Common clinical features include:

• Joint stiffness and contractures
• Corneal clouding
• Carpal tunnel syndrome
• Hearing loss
• Cardiac abnormalities, such as valvular heart disease
• Hernias

Unlike the more severe forms of MPS I, individuals with Scheie syndrome usually have normal intelligence and a normal lifespan.

Diagnosis

The diagnosis of Scheie syndrome is based on clinical evaluation, family history, and laboratory tests. Enzyme assays can measure the activity of alpha-L-iduronidase in blood or fibroblasts. Genetic testing can confirm mutations in the IDUA gene.

Treatment

There is no cure for Scheie syndrome, but treatment focuses on managing symptoms and improving quality of life. Options include:

• Enzyme replacement therapy (ERT) with laronidase
• Surgical interventions for carpal tunnel syndrome and corneal clouding
• Physical therapy to maintain joint mobility

Prognosis

The prognosis for individuals with Scheie syndrome is generally good, with most individuals leading a normal lifespan. However, they may experience progressive symptoms that require ongoing management.

See also

• Mucopolysaccharidosis
• Hurler syndrome
• Hurler-Scheie syndrome
• Genetic disorders